Page 250 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.3. Trends in mortality rates (per 100,000 person-yr unless otherwise stated) or survival (continued)
Author Database Groups 1980-84 1985-89 1990-94 1995-99 2000-04 2005-10 Statistical Notes
Year (yr) analysis
PMID
76
Danley LAC/USC White – non 0.5 (-0.2, P>0.05 Additional
1995 CSP Hispanic 1.2) (difference information
8580296 Black/African 0.3 (-1.8, between is
American 2.5) racial/ethnic presented
Asian 1.6 (0.0, groups for in Figure 1
Percent annual 3.2) the linear of the
change in age- 2.3 (-2.9, trend over yr, paper.
adjusted 7.80 1976-88)
mortality rates
(95% CI) using
1976 as the
baseline
Patient
characteristics –
Comorbidities
24
Merrill SEER No Referent Referent Referent OR (95% CI) Data were
2000 Yes 0.36 (0.32, 0.38 (0.34, 0.35 for death reported
10792091 Multiple 0.41 0.43) (0.32, from prostate only for
primary (1988-89) (1992-93) 0.40) cancer vs. White and
cancers (1994- non-prostate Black
95) cancer, patients.
stratified by
comorbidity
status
Tumor
characteristics –
stage
18
Chu SEER Local/regional 98% 100% NR
2003 Distant 84% 81%
12627516 Unstaged 96% 97%
1 yr survival (1981-85) (1992-
rates of 97)
patients
diagnosed with
prostate cancer
by year of
diagnosis
[White]

C-43